Trust patient is first participant in Europe to join study of new treatment for rare bleeding disorder
Trust patient is first participant in Europe to join study of new treatment for rare bleeding disorder ...
Trust patient is first participant in Europe to join study of new treatment for rare bleeding disorder ...
Blocking Galectin-1 can make thermal ablation more effective and reduce risk of recurrence A new study led by investigators at...
A new study presented at the American Diabetes Association’s 85th Scientific Sessions revealed that smartphone-enabled home testing can improve early...
Fatty liver disease affects more than a third of adults in the United States, a silent epidemic closely tied to...
The study explored the views of healthcare providers in three health facilities regarding the barriers to accessing haemodialysis in northern...
image: Interleukin 33 (brown) upregulation in hepatitis B virus-positive chronic hepatitis. view more Credit: Shawn Demehri, Mass General Brigham Hepatitis B...